OverviewChartTechnicalNewsTraderScreen

CIPHER PHARMACEUTICALS INC/  CA17253X1050  /

Toronto
2024-06-25  5:45:01 PM Chg. -0.06 Volume Bid5:45:10 PM Ask5:45:10 PM High Low
8.40CAD -0.71% 402
Turnover: 3,360		 8.36Bid Size: 100 8.40Ask Size: 2,800 8.40 8.40
Newsfile Corp 04-03 Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Co...
GlobeNewswire 01-29 OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX
Newsfile Corp 2023-04-18 Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
GlobeNewswire 2021-08-12 Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Cran...
GlobeNewswire 2019-08-08 Aclaris Therapeutics Reports Second Quarter 2019 Financial Results, Provides Business Strategy Updat...
GlobeNewswire 2019-03-18 Aclaris Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Update...
GlobeNewswire 2018-07-20 HSR Act Waiting Period Terminated for United Therapeutics’ Acquisition of SteadyMed Ltd.
GlobeNewswire 2018-05-08 Aclaris Therapeutics Reports First Quarter 2018 Financial Results and Provides Update on Clinical an...
GlobeNewswire 2018-04-30 United Therapeutics to Acquire SteadyMed Ltd.
GlobeNewswire 2018-04-06 Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercial...
GlobeNewswire 2018-03-30 SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
GlobeNewswire 2017-08-25 World Prescription Dermatological Drugs Market 2017: New Biologics and Their Uses in Dermatology / M...
GlobeNewswire 2017-03-27 Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Operational ...